drugset / Trial / NCT00789152

The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)

NCT00789152

Phase 3 Completed 81 enrolled Organon and Co
RandomizedCrossoverTriple-blindTreatment

Summary

This was a study to measure the ability of desloratadine and levocetirizine to decrease nasal obstruction in subjects who had study-induced allergic rhinitis. Study participants had allergic rhinitis symptoms induced in a Vienna Challenge Chamber and then received desloratadine or levocetirizine for 8 days. After at least a 10 to 35-day washout period (time when no drug is given), subjects received the opposite treatment for 8 days. Subjects had their total nasal symptom measured.on the 8th day of each treatment period.

Timeline

Start
2003-12-01
Primary completion
2004-05-01
Completion
2004-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Desloratadine Small molecule 5 mg
Subject Levocetirizine Unknown 5 mg

Indications